Kidney Cancer Diagnostics Market will Account for Around US$ 700 Mn Revenues by 2022
Tremendous transformations have been witnessed over the recent past, in the management and diagnosis of renal cell carcinoma (RCC), or, kidney cancer. Numerous discoveries, trails, and studies have been taken in active surveillance, renal biopsy, as well as minimally-invasive thermal ablation, on the back of surging diagnosis rate of the small renal masses, observed usually among individuals with high morbidity risks, undergoing operative treatment. These factors are expected to fuel growth of the global market for kidney cancer diagnostics.
Older population are most commonly affected by kidney cancer. Diagnosis of old-aged patients makes kidney cancer diagnostics an intricate chapter in the medical books. MRI and CT scan are staple diagnosis procedures in the global market for kidney cancer diagnostics, however, patients are anticipating the emergence of advanced and more effective diagnosis tests. Moreover, this urge to upgrade the diagnostic approach for kidney cancer patients is also resonated by medical organizations as they continue to direct heavy investments in research & developments of new diagnostic procedures. Improvements in early diagnosis tests have translated huge profits for market players, and these companies are also partnering with medical research organizations to develop diagnostic methods that can concurrently lower the maturation pace of tumor between multiples stages of kidney cancer.
Request For Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=56
9 Estimations from Fact.MR’s Report on the Global Kidney Cancer Diagnostics Market
Based on end-users, the hospital-associated labs will remain preferred in the market for kidney cancer diagnostics, and are expected to account for the largest revenues over the forecast period.
Independent diagnostic laboratories are estimated to remain the second largest end-users in the global market for kidney cancer diagnostics.
Cancer research institutes will register the fastest expansion in the market during the forecast period.
Immunochemistry tests will remain sought-after in the market for kidney cancer diagnostics, and revenues from these tests will account for US$ 351.8 Mn by 2022-end. Among test type, Immunochemistry test is expected to exhibit the highest CAGR through 2022, followed by the complete blood count test.
Check Discount @ https://www.factmr.com/connectus/sample?flag=D&rep_id=56
Urine analysis is anticipated to remain the second most lucrative tests for diagnosis of kidney cancer across the globe.
Revenues from blood chemistry tests related to kidney cancer diagnostics are expected to remain comparatively lower in the market over the forecast period.
North America will continue to account for the largest revenues in the kidney cancer diagnostics market, followed by Europe.
Market for kidney cancer diagnostics in Europe will register a relatively higher CAGR than in North America throughout the forecast period.
Asia Pacific excluding Japan (APEJ) is expected to remain the fastest growing market for kidney cancer diagnostics over the forecast period.
The report has also profiled leading players in the global market for kidney cancer diagnostics, which include NeoGenomics Laboratories, Myriad Genetics Inc, NanoString Technologies Inc., Rosetta Genomics, Sysmex Corporation, Illumina, Inc., Roche Holding AG, Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., and Abbott Laboratories.
Click to View Complete Report @ https://www.factmr.com/report/56/kidney-cancer-diagnostics-market
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Office: Dublin 2
27 Upper Pembroke Street,
Dublin 2, Ireland
( Dublin 2 )
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kidney Cancer Diagnostics Market will Account for Around US$ 700 Mn Revenues by 2022 here
News-ID: 696603 • Views: 136
More Releases from Fact.MR
Vegan Baking Ingredients Market Expected to Witness the Highest Growth during 20 …
According to a recent report by FactMR, vegan baking ingredients sales are expected to close in on 38,000 tons in 2019. Widespread adoption of veganism coupled with pervasive trends such as “mindful choices”, “clean label”, and “sustainability” continue to impact growth of the vegan baking ingredients market. The Fact.MR report tracks the vegan baking ingredients market for the period 2018-2028. According to the report, the vegan baking ingredients market is
Ready-to-Fill Pastry Market Upcoming Trends and Key Growth Factors during 2019-2 …
The ready-to-fill pastry market is experiencing a buzzing growth of more than 6% during the forecast period and several significant companies are investing their time and efforts in the ready-to-fill pastry market under the influence of increased demand for convenient and easily available foods. The trends in the bakery industry also have a noteworthy impact on the northward growth of the ready to fill pastry market. The rising consumer demand
Rail Gangways Market Assessment Based on Top Driving Factors during 2018-2028 | …
Growing need for rail gangways in various countries on the coattails of ongoing railway infrastructure development along with new construction of metro rails is anticipated to accelerate the growth of rail gangways market across the globe. The global rail gangways market is expected to be valued at US$ 392.8 million in 2018, expanding at a significant CAGR of 4.9% over the forecast period (2018-2028). Rising investments in railway developments and upcoming metro
Pod Vapes Market Progress and Top Manufacturer Contribution Forecast Report betw …
A recent study of Fact.MR estimates sales of pod vapes to reach 500 million units in 2019, and register a Y-o-Y growth of 18.5% over 2018. Growth of the pod vapes market can be attributed to the rising concerns about the adverse impact of smoking on health and availability of a multitude of flavored pod vapes. The Fact.MR report also tracks the pod vapes market for the period 2018-2027. The
More Releases for Cancer
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and